Companies formed
Since 1987, Oxford University Innovation has been responsible for creating spinout companies based on academic research generated within and owned by the University of Oxford, and in recent years has spun out 15-20 new companies every year.
Over £2.5bn in external investment has been raised by Oxford University Innovation spinouts since 2010, and ten of our current portfolio are currently listed in London and New York.
The creation of new spinout companies, most of which are listed below, also channels millions of pounds back into University research, benefits local economic development and has created many new jobs in the region.
Oxonomy


Maritime trade and transport simulation.
Incorporated in February 2017
Origin: Oxford University, Geography, Maths, Computer Sciences, Engineering
Covatic


A broadcast personalisation engine to revolutionise audience experience.
Incorporated in January 2017
Origin: Oxford University, Department of Computer Science
2016
Oxford VR


Virtual Reality software to help treat people with severe paranoia by allowing them to face situations that they fear.
Incorporated in December 2016
Origin: Oxford University, Psychiatry
MetaBoards


Ubiquitous wireless power and data using metamaterials.
Incorporated in December 2016
Origin: Oxford University, Department of Engineering Science
EnzBond


EnzBond aims to change the current understanding of enzyme evolution process.
Incorporated in November 2016
Origin: Oxford University, Department of Chemistry
Proxisense


Proxisense specialise in advanced sensors, diagnostics and optimisation systems to prevent downtime & equipment failure. They improve performance & efficiency of complex rotating equipment.
Incorporated in October 2016
Origin: Oxford University, Department of Engineering Science
Circadian Therapeutics


Circadian Therapeutics identify and bring to market pharmaceutical and diagnostic platforms for the effective management of physiological and pathological conditions through their ability to modify the body's circadian rhythms.
Incorporated in September 2016
Origin: Oxford University, Ophthalmology
iota Sciences


Develop technologies that miniaturise fluid handling to accelerate drug discovery.
Incorporated in September 2016
Origin: Oxford University, Department of Pathology
OxSight


The OxSight ‘SmartSpecs’ help sight impaired and blind people to navigate independently, avoid collisions and see in the dark.
Incorporated in June 2016
Origin: Oxford University, Neuroscience
Osler Diagnostics (Oxford Impedance Diagnostics)


Researches, designs and will market diagnostic tests for the measurement of clinical bio markers that reduce healthcare costs and improve patient outcomes.
Incorporated in June 2016
Origin: Oxford University, Department of Chemistry
OxStem


OxStem is a developer of cell programming therapies.
Incorporated in May 2016
Origin: Oxford University, Department of Chemistry
Oxford Nanoimaging


Oxford Nanoimaging’s microscope, the Nanoimager, is a single-molecule fluorescence microscope.
It is about 30 times smaller and significantly less expensive than current super-resolution microscopes and will be manufactured in the UK.
Incorporated in May 2016
Origin: Oxford University, Department of Physics
EvOx Therapeutics


EvOx Therapeutics harnesses the body’s own precision communications system to deliver drugs to specific parts of the body, with the aim of treating conditions which are currently untreatable including those affecting the brain, as well as autoimmune diseases and cancers.
Incorporated in April 2016
Origin: Oxford University, Neuroscience
Argonaut


The development of cancer drugs that reprogram cancer cells to undergo the body's natural process of cell death.
Incorporated in April 2016
Origin: Oxford University, Sir William Dunn School of Pharmacology
DiffBlue


DiffBlue is a world leader in automated test generation. Their products have been developed with industry partners over the last ten years and replace the manual process of writing tests.
Incorporated in March 2016
Origin: Oxford University, Department of Computer Science
Vaccitech


The company has been formed around two viral vector vaccines, one to prevent influenza and the other to treat prostate cancer.
Incorporated in March 2016
Origin: Oxford University, Jenner Institute
OMass


Specialise in applying state-of-the-art mass spectrometry platforms to characterising intact protein assemblies, often referred to as native mass spectrometry.
Incorporated in March 2016
Origin: Oxford University, Department of Chemistry
Mind Foundry


A software that uses advanced algorithms and techniques to solve problems.
Incorporated in February 2016
Origin: Oxford University, Department of Engineering Science
Zegami


Data discovery software to manage and sort collections of images and data visually.
Incorporated in January 2016
Origin: Oxford University, Sir William Dunn School of Pathology
2015
Oxford Endovascular


Developing tiny metallic mesh tube devices to treat patients suffering from brain aneurysms.
Incorporated in December 2015
Origin: Oxford University, Department of Engineering Science